JP2025500347A5 - - Google Patents
Info
- Publication number
- JP2025500347A5 JP2025500347A5 JP2024537381A JP2024537381A JP2025500347A5 JP 2025500347 A5 JP2025500347 A5 JP 2025500347A5 JP 2024537381 A JP2024537381 A JP 2024537381A JP 2024537381 A JP2024537381 A JP 2024537381A JP 2025500347 A5 JP2025500347 A5 JP 2025500347A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163252559P | 2021-10-05 | 2021-10-05 | |
| US63/252,559 | 2021-10-05 | ||
| PCT/US2022/077628 WO2023060142A2 (en) | 2021-10-05 | 2022-10-05 | Engineered cardiac muscle compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025500347A JP2025500347A (ja) | 2025-01-09 |
| JP2025500347A5 true JP2025500347A5 (https=) | 2025-10-15 |
| JPWO2023060142A5 JPWO2023060142A5 (https=) | 2025-10-15 |
Family
ID=85803752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024537381A Pending JP2025500347A (ja) | 2021-10-05 | 2022-10-05 | 操作された心筋組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240409956A1 (https=) |
| EP (1) | EP4413025A2 (https=) |
| JP (1) | JP2025500347A (https=) |
| CN (1) | CN118339176A (https=) |
| AU (1) | AU2022360985A1 (https=) |
| CA (1) | CA3236534A1 (https=) |
| WO (1) | WO2023060142A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022173847A2 (en) * | 2021-02-09 | 2022-08-18 | Affinia Therapeutics Inc. | Recombinant aavs with improved tropism and specificity |
| MX2024004217A (es) | 2021-10-08 | 2024-06-26 | Dyno Therapeutics Inc | Variantes de cápside y métodos de uso de estas. |
| WO2025024254A2 (en) * | 2023-07-21 | 2025-01-30 | The Trustees Of Indiana University | Aav vector formulation |
| WO2025048709A1 (en) * | 2023-08-25 | 2025-03-06 | Agency For Science, Technology And Research | Composition and methods for identification of novel aav variants for differentiated gene delivery to cardiomyoctes and/or skeletal myofibers |
| WO2025160155A1 (en) | 2024-01-22 | 2025-07-31 | The Broad Institute, Inc. | Epigenetic targeting of prion diseases |
| WO2026006391A1 (en) * | 2024-06-25 | 2026-01-02 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Compositions and methods for treating a heart disease |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7314974B2 (en) * | 2002-02-21 | 2008-01-01 | Monsanto Technology, Llc | Expression of microbial proteins in plants for production of plants with improved properties |
| AU2020368539A1 (en) * | 2019-10-16 | 2022-04-28 | Massachusetts Institute Of Technology | Engineered muscle targeting compositions |
-
2022
- 2022-10-05 AU AU2022360985A patent/AU2022360985A1/en active Pending
- 2022-10-05 CA CA3236534A patent/CA3236534A1/en active Pending
- 2022-10-05 EP EP22879462.4A patent/EP4413025A2/en active Pending
- 2022-10-05 CN CN202280079514.3A patent/CN118339176A/zh active Pending
- 2022-10-05 JP JP2024537381A patent/JP2025500347A/ja active Pending
- 2022-10-05 WO PCT/US2022/077628 patent/WO2023060142A2/en not_active Ceased
- 2022-10-05 US US18/698,929 patent/US20240409956A1/en active Pending